Donald Trump has escalated his trade offensive by imposing 50% tariffs on most U.S. imports from India, punishing the world’s fifth-largest economy for continuing to buy discounted Russian oil.
EU Unveils $72bn Tariff Plan as Trade Tensions With US Escalate
The European Union has put forward proposals for a new wave of retaliatory tariffs on US goods worth $72bn (£62.4bn), following President Donald Trump’s threat to impose 30% levies on
Rob Naylor, incoming CEO Intuitive Investments Group (IIG.L) Interview
The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast-growing and/or high potential Life Sciences businesses operating predominantly in the
TPI provides its latest research note on Intuitive Investments Group (IIG.L).
IIG has today been Admitted onto London’s AIM. IIG is an investment group that seeks to leverage the expertise and extensive networks of its Board and Advisory Panel in the
Two Shields Inv. PLC (TSI.L) BrandShield Update
Two Shields Investments plc, the AIM quoted investment company with a strategy to build a high-quality portfolio of investments in fast growing and scalable digital and technology enabled businesses.
Two Shields Inv. PLC (TSI.L) BrandShield Update
Two Shields Investments plc, the AIM quoted investment company with a strategy to build a high-quality portfolio of investments in fast-growing and scalable digital and technology-enabled businesses, is pleased to
The UK could legalise cannabis in next five years
Say tycoons hoping to make a fortune out of a booming British pot industry Britain could legalise cannabis in the next five years, say experts in the industry
GlaxoSmithKline plc (LSE/NYSE:GSK) Trelegy Ellipta: positive opinion from CHMP Europe
GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion